The Rosen Law Firm, a global investor rights law firm, announced it is investigating potential securities claims on behalf of KBR, Inc. (NYSE: KBR) investors. The investigation stems from accusations that KBR released potentially misleading information to the public.
The firm alleges that KBR‘s June 20, 2025 press release concerning the termination of a contract by the U.S. Transportation Command (TRANSCOM) with HomeSafe Alliance, a KBR joint venture, may have contained inaccurate or incomplete information. This announcement reportedly led to a significant drop in KBR‘s stock price.
Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by investors. Investors who purchased KBR securities during the relevant period may be able to participate in this action and potentially receive compensation without incurring any out-of-pocket expenses, as the firm operates on a contingency fee basis.
The firm highlights its extensive experience and success in securities class action litigation. They cite a history of significant settlements, including what was at the time the largest ever securities class action settlement against a Chinese company. The firm also emphasizes its consistent high rankings in securities class action settlements.
Rosen Law Firm encourages investors to carefully consider their legal counsel when pursuing such claims, recommending the selection of firms with a proven track record and substantial resources. They contrast their experience and resources with those of firms that may not actively litigate these types of cases.
Interested investors can learn more about joining the potential class action by contacting Phillip Kim, Esq. at the Rosen Law Firm. The firm’s contact information includes a toll-free number and email address for inquiries. The firm has offices in New York, NY.
The Rosen Law Firm‘s announcement serves as a reminder for investors to remain vigilant and informed about potential legal recourse in cases of suspected corporate misrepresentation. The firm emphasizes that past results do not guarantee similar outcomes in future cases.










